Legislation enabling the substitution and use of potentially life-saving medications called “biosimilars” was approved on final reading by the Nebraska legislature on a vote of 47-0. The bill now goes to Governor Pete Ricketts for his expected signature.
According to the bill’s sponsor, Senator John Kuehn of Heartwell, biosimilars are an innovative class of pharmaceuticals that provide treatment options for health care providers and patients.
Nebraska becomes the 32nd state to adopt this legislation.
